James Christopher Barry - 01 Nov 2021 Form 4 Insider Report for NUVASIVE INC

Role: Chief Executive Officer, Director
Signature: /s/ Nathaniel B. Sisitsky, Attorney-in-fact for James Christopher Barry
Issuer symbol: N/A
Transactions as of: 01 Nov 2021
Net transactions value: $0
Form type: 4
Filing time: 03 Nov 2021, 17:50:38 UTC
Previous filing: 29 Jun 2021
Next filing: 09 Nov 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUVA	PRSUs	Award	$0	+29,904		$0.000000	29,904	01 Nov 2021	Common Stock	29,904	$0.000000	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting.
F2	This PRSU award was granted to the Reporting Person on November 5, 2018. The award was granted subject to performance conditions based on the level of year-over-year improvement in the Issuer's non-GAAP earnings per share during the three-year performance period ended September 30, 2021. On November 1, 2021, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 29,904 shares on November 5, 2021, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant.

Content

Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting.

This PRSU award was granted to the Reporting Person on November 5, 2018. The award was granted subject to performance conditions based on the level of year-over-year improvement in the Issuer's non-GAAP earnings per share during the three-year performance period ended September 30, 2021. On November 1, 2021, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 29,904 shares on November 5, 2021, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant.